Richard E. Uihlein, Chairman
Chair of the BoardatGalectin Therapeutics· In proxies 2023–2025
Richard E. Uihlein, Chairman is Chair of the Board of Galectin Therapeutics.
Experience
- Galectin TherapeuticsPublic company · 3 yr
- Chair of the Board2023 – Present · 3 yrStock in role +215%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?